The newly created board met virtually in July to assess the ethics of proposed research grants involving fetal tissue.
In a report sent to HHS Aug. 18, the advisory board recommended NIH fund only one of 14 fetal tissue research grants. The one proposal recommended for funding involved using fetal tissue to assess whether an alternative research mechanism that does not use the tissue is also effective. The most common reason the board recommended withholding funding was that researchers did not provide adequate ethical justification for using fetal tissue, according to The Post.
Many scientists who work with fetal tissue have spoken out against the recommendations, claiming the White House is effectively trying to ban all fetal tissue research.
Ultimately, HHS Secretary Alex Azar has final say over the projects NIH funds.
To view the full article, click here.
More articles on leadership and management:
Henry Ford’s new marketing chief on building trust, surprise and delight in healthcare
16 healthcare organizations recognized as Employers of Excellence for PAs
Too much positivity is toxic, psychologists say
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
